January 26th, 2024
This conference has already taken place.
Description
The field of hematology is rapidly changing with new data being published and treatment options being updated year-round. These updates are practice-changing and need to be incorporated into clinical practice to provide optimal care. Physicians and health care providers find it difficult to stay on top of all recent developments and therefore, may not be applying the most recent treatments and practices in patient care. This activity will seek to close that gap in knowledge and competence by providing a review of the latest updates from the December 2023 American Society of Hematology (ASH) Meeting.
For pricing information, see pricing tab below.
Dates and Times
Start: 1/26/2024 7:00 AM
End: 1/26/2024 1:00 PM
Objectives
At the conclusion of this activity, learners will be able to:
1. Comprehend the new practice-changing information regarding the diagnosis and treatment of benign and malignant hematologic disorders and employ the knowledge gained to improve patient care.
2. Discuss innovative, practice-changing, state-of-the-art research in hematology.
3. Analyze early phase clinical trial data and consider how it may translate to the current evidence-based management of hematologic disorders.
Agenda
Ohio State’s 2024 ASH Review
Friday, January 26, 2024
7 a.m. - 1:00 p.m. Fawcett Event Center
7 am. Registration and Breakfast
8 a.m. Welcome and Overview
Srinivas Devarakonda, MD
Associate Professor, Division of Hematology OSUCCC – James
Narendranath Epperla, MD, MS
Assistant Professor, Division of Hematology OSUCCC – James
SESSION I
8:05 a.m. Lymphoma
Walter Hanel, MD, PhD
Assistant Professor, Division of Hematology OSUCCC – James
8:25 a.m. Chronic Lymphocytic Leukemia
Seema Bhat, MD
Associate Professor, Division of Hematology OSUCCC – James
8:45 a.m. Multiple Myeloma
Abdullah Khan, MBBS
Assistant Professor, Division of Hematology OSUCCC – James
9:05 a.m. Allo SCT
Sarah Wall, MD
Assistant Professor, Division of Hematology OSUCCC – James
9:25 a.m. Q&A
9:40 a.m. Break
SESSION II
10:00 a.m. MDS and AML
Uma Borate, MD
Associate Professor, Division of Hematology OSUCCC – James
10:20 a.m. Myeloproliferative Neoplasms
Andrew Srisuwananukorn, MD
Assistant Professor, Division of Hematology OSUCCC – James
10:40 a.m. Benign Hematology
Sherraine Della-Moretta, MD
Assistant Professor, Division of Hematology OSUCCC – James
11:00 a.m. Q&A
11:15 a.m. Lunch
SESSION III
11:45 a.m. Michael R. Grever, MD, Distinguished Professor Lectureship
Don Benson, MD, PhD
Professor in the Division of Hematology OSUCCC - James
Director of the Myeloma Program
12:45 p.m. Q&A
1:00 p.m. Evaluations and Adjourn
Pricing
| Tier | Price |
|---|---|
| This is a Free Event | $0.00 |
Speakers
Location
The Fawcett Center
2400 Olentangy River Rd.
Columbus, OH 43210
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.